Testosterone MD-Lotion
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Hypogonadism
Conditions
Hypogonadism
Trial Timeline
Oct 1, 2008 → Aug 1, 2009
NCT ID
NCT00857454About Testosterone MD-Lotion
Testosterone MD-Lotion is a phase 3 stage product being developed by Eli Lilly for Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT00857454. Target conditions include Hypogonadism.
What happened to similar drugs?
6 of 18 similar drugs in Hypogonadism were approved
Approved (6) Terminated (3) Active (11)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00857454 | Phase 3 | Completed |
| NCT00702650 | Phase 3 | Completed |
| NCT00857961 | Phase 2 | Completed |
Competing Products
20 competing products in Hypogonadism